Selank is a synthetic tuftsin-analog peptide studied mainly for anxiety.3 It is not FDA-approved in the United States, and online “research use only” products are not approved medicines for people. Its U.S. status depends on the activity involved—marketing, prescribing, dispensing, or compounding—not simply whether a website will sell it.
Wondering if peptide therapy is right for you? Take the 3-min clinical quiz.
See if you qualify →What is Selank, and why is its U.S. legal status confusing?
Selank, sometimes called selank acetate or TP-7, is a synthetic heptapeptide modeled on tuftsin, a naturally occurring immune-system peptide fragment. It has been studied as an anxiolytic, meaning a substance investigated for anxiety-related symptoms. Its status is confusing because scientific research, foreign registration, online research sales, and U.S. drug approval are not the same thing.3 8
A substance can appear in a paper or be sold by a website without becoming an FDA-approved medicine. In the U.S., FDA approval is based on review of a specific drug product for safety, effectiveness, quality, and labeling. The FDA’s public Drugs@FDA database is the practical starting point for checking approved human drug products.1
- Selank is a peptide studied in limited human and preclinical research.
- Selank is not listed as an FDA-approved drug product in Drugs@FDA.1
- A website’s “research use only” language is not a human-use authorization.
- A clinician’s involvement does not turn an unapproved substance into an FDA-approved drug.
Is Selank FDA-approved in the United States?
No. Selank is not FDA-approved in the United States, and the FDA Drugs@FDA database does not identify it as an approved drug product.1 That means it does not have an FDA-approved indication for generalized anxiety disorder, focus, sleep, or any other condition.
This does not erase the published research or reports of Russian regulatory history. It means those facts should not be presented as U.S. approval. Small studies and a foreign regulatory pathway do not replace FDA review of a drug product’s manufacturing, labeling, safety, and effectiveness for U.S. patients.1 3
Is Selank a controlled substance?
FDA approval and controlled-substance scheduling are separate legal questions. The FDA approval database is not a controlled-substance schedule, so the absence of Selank from Drugs@FDA does not by itself answer every federal or state controlled-substance question.1 For a current determination, check federal and state materials or speak with a qualified legal or pharmacy professional rather than relying on a seller’s product page.
Can a seller legally market Selank for human use?
A seller should not represent an unapproved product as an FDA-approved medicine for anxiety, cognition, or another human condition. FDA approval is product-specific, and approved products can be checked through Drugs@FDA.1 Marketing language such as “for anxiety,” “prescription-ready,” or “FDA registered” should not be confused with FDA approval of Selank itself.
What does a research-use-only label mean?
“Research use only” describes a product’s stated intended use; it does not make the product an approved medication or authorize self-administration. It is especially important to separate that label from claims about purity, sterility, identity, or suitability for use in people. For a broader guide to this distinction, see our article on research-only peptides versus prescription access.
Can Selank be prescribed or compounded in the United States?
There is no standard FDA-approved prescription pathway for Selank. Section 503A provides a limited federal framework for pharmacy compounding, including conditions related to bulk drug substances; it is not a blanket permission to compound any peptide sold online.2
Whether a particular pharmacy can compound a particular substance depends on current federal requirements and the facts of that situation. Patients should be cautious with websites that present a clinician visit, a “pharmacy partner,” or an FDA registration claim as proof that Selank is FDA-approved or broadly eligible for compounding. Those are different claims.1 2
How do FDA bulk-substance rules affect 503A pharmacy compounding?
Under Section 503A, a state-licensed compounding pharmacy must meet conditions when using a bulk drug substance. FDA explains that a bulk substance may be used only under specific pathways, such as appearing on an applicable list or meeting other statutory criteria.2 Those rules can change, so current FDA materials—not an online store’s description—are the appropriate source for regulatory-status checks.
Why does clinician review not make an unapproved product FDA-approved?
A licensed clinician can evaluate symptoms and discuss treatment options, but FDA approval applies to a drug product and its labeled uses, not to the fact that someone reviewed a questionnaire. A medical evaluation may be valuable for safety, but it does not establish that Selank has FDA-reviewed safety, effectiveness, quality, or dosing information.1 2
What should you question when a site says Selank is prescription-ready or FDA-registered?
- Does the site clearly distinguish FDA approval from business registration, clinician review, or pharmacy licensing?
- Does it avoid presenting “research use only” as a path to human treatment?
- Does it name the dispensing pharmacy and describe its state license accurately?
- Does it make claims that go beyond the limited human evidence?
- Does it encourage replacing prescribed anxiety treatment without a clinician’s guidance?
What human research has been published on Selank?
Human research on Selank exists, but it is limited. Most published clinical reports are small and largely from Russian-language literature, including studies involving anxiety disorders and a comparison with phenazepam, a benzodiazepine used in some countries.3 4 5
These reports are signals for further study, not FDA-level proof of effectiveness or safety. Individual results vary, and the available publications do not establish the long-term effects, appropriate dosing, interaction profile, or real-world outcomes needed to treat Selank as an established anxiety medication.3 4 5
What did small Russian clinical studies report?
A 2008 publication evaluated Selank in people with generalized anxiety disorder and neurasthenia, while later reports examined Selank in anxiety-disorder treatment and compared it with phenazepam.3 4 5 These papers support the narrow statement that human clinical research has been published; they do not establish that Selank should replace established care.
Why do these studies not establish FDA-level evidence of safety or effectiveness?
Drug approval generally relies on a body of well-controlled evidence plus detailed product-quality and safety review. A few small studies cannot answer key patient questions about rare adverse effects, long-term use, pregnancy, interactions with psychiatric medicines, or how a specific product performs outside a study setting.1 3 5
What can animal and cell research tell patients?
Animal and cell work can help researchers form hypotheses about mechanism. For example, a preclinical study reported changes in genes related to GABAergic neurotransmission after Selank administration in an animal research model.6 A newer transcriptomic report also examines early gene-expression effects.7
That does not prove that Selank changes GABA signaling in people, works for anxiety, or has the same effects as a prescription anxiety medicine. Animal, cell, and gene-expression findings are preclinical—not demonstrated patient benefits.6 7
Does Selank feel like Xanax or work like a benzodiazepine?
No reliable evidence supports treating Selank as the same as alprazolam (Xanax) or another benzodiazepine. Benzodiazepines are an established drug class with known FDA labeling, while Selank has limited human research and no FDA-approved U.S. indication.1 3
A published Selank-versus-phenazepam comparison does not make Selank interchangeable with phenazepam, alprazolam, or any other benzodiazepine.4 Do not stop, reduce, or replace prescribed anxiety medicine based on online peptide claims. Sudden changes to some psychiatric medications can carry meaningful risks and should be managed by the prescribing clinician.
Is Selank safe to take?
The honest answer is that long-term Selank safety remains unknown. Published clinical studies provide limited information, but they do not establish the full range of side effects, medication interactions, risks in pregnancy, effects with long-term use, or safety of products sold outside regulated drug channels.3 4 5
Product quality is a separate concern from the molecule itself. A research-use-only listing does not demonstrate that a product has been evaluated as a human medicine for identity, strength, sterility, or labeling. FDA’s approval process and the compounding framework address different regulatory pathways, neither of which should be assumed from a web listing.1 2
Does Selank show up on drug tests?
This article cannot determine whether Selank will appear on a particular drug test. Anyone subject to testing should ask the testing program or a qualified clinician before using any unapproved substance.
Which peptides have clearer legal or prescription pathways in the U.S.?
The clearest path is an FDA-approved medication used under its approved labeling. FDA-approved peptide medicines and investigational peptides are not interchangeable categories; each medication’s evidence, indication, formulation, and regulatory status must be checked separately in current FDA sources.1
| Category | What it means | What patients should verify |
|---|---|---|
| FDA-approved drug | FDA has reviewed a specific drug product and labeling for approved uses. | The product, indication, warnings, and current label in FDA resources.1 |
| Compounded medication | A patient-specific medication prepared under applicable compounding requirements. | The prescriber’s assessment, pharmacy license, and applicable 503A requirements.2 |
| Research-use-only peptide | A product represented for laboratory research, not as an approved human medicine. | That the label does not authorize treatment, self-administration, or medical claims. |
| Investigational peptide | A substance being studied but not established as an approved treatment. | Whether claims reflect human evidence rather than animal or cell findings. |
For example, Semax and Selank are often discussed together online because both originated in Russian peptide research, but one compound’s claims or legal discussion should never be used to prove the status of the other. Our Selank evidence and safety guide and guide to buying peptides online explain why source quality and regulatory claims matter.
How can you discuss anxiety symptoms with a licensed clinician?
If anxiety is affecting sleep, work, relationships, or daily life, a licensed clinician can help assess possible causes and discuss evidence-based options. Bring a list of symptoms, current medications and supplements, prior treatment experiences, and questions about side effects or interactions.
Chia does not offer Selank, prescribe it, compound it, dispense it, or ship it. If you are considering any peptide or are worried about anxiety symptoms, seek an appropriate clinical evaluation rather than relying on a research-chemical seller. Urgent mental-health concerns, thoughts of self-harm, or feeling unsafe require immediate local emergency or crisis support.
There is no simple yes-or-no answer based only on whether a website sells it. Selank is not FDA-approved in the United States, and the legal analysis differs for research sales, marketing for human use, prescribing, and pharmacy compounding.
No. Selank is not FDA-approved for any indication in the United States.
A website may list a product, often as research use only, but that label does not authorize human treatment or self-administration. Online availability is not proof of FDA approval, product quality, or a lawful prescription pathway.
There is no standard FDA-approved U.S. prescription pathway for Selank. A clinician visit does not itself make Selank FDA-approved or confirm that a specific product can be compounded.
Section 503A has specific conditions for compounding from bulk drug substances and is not blanket permission to compound every peptide. Current FDA materials and the facts involving the pharmacy and prescription matter.
Controlled-substance scheduling is separate from FDA approval. Do not use the FDA approval database or an online seller’s claims as a substitute for current federal and state scheduling information.
Published sources describe Selank as having a Russian regulatory history, but that history does not create FDA approval or an approved U.S. indication.
Semax and Selank are separate compounds. Their evidence, marketing claims, and regulatory status should be checked individually rather than inferred from one another.
References
- 1.U.S. Food and Drug Administration. Drugs@FDA: FDA Approved Drug Products. 2026.
- 2.U.S. Food and Drug Administration. Bulk Drug Substances Used in Compounding Under Section 503A of the Federal Food, Drug, and Cosmetic Act. 2026.
- 3.Zozulia AA, Neznamov GG, Siuniakov TS, et al. Efficacy and possible mechanisms of action of a new peptide anxiolytic Selank in the therapy of generalized anxiety disorders and neurasthenia. Zhurnal Nevrologii i Psikhiatrii imeni S.S. Korsakova. 2008.
- 4.Medvedev VE, Tereshchenko ON, Israelian AIu, et al. A comparison of the anxiolytic effect and tolerability of Selank and phenazepam in the treatment of anxiety disorders. Zhurnal Nevrologii i Psikhiatrii imeni S.S. Korsakova. 2014.
- 5.Medvedev VE, Tereshchenko ON, Kost NV, et al. Optimization of the treatment of anxiety disorders with Selank. Zhurnal Nevrologii i Psikhiatrii imeni S.S. Korsakova. 2015.
- 6.Kolomin T, Shadrina M, Slominsky P, et al. Selank Administration Affects the Expression of Some Genes Involved in GABAergic Neurotransmission. Frontiers in Pharmacology. 2016.
- 7.Transcriptomic Effects of Peptide Drug Selank during Early Administration. Bulletin of Experimental Biology and Medicine. 2026.
- 8.SelankCo. Selank FAQ: What the Research Actually Shows. 2026.
About this article
Chia Health Editorial Team — Evidence-reviewed health education
This article is for educational purposes only and is not a substitute for individualized medical advice. Talk to a licensed clinician before starting, stopping, or changing any prescription.
AI tools may assist with research and drafting. Chia's editorial team reviews source use, clarity, treatment information, and safety framing before publication. A clinician is named only after explicit sign-off. Read our editorial standards.
Get a personalized plan
See if peptide therapy is right for your body.
Our 3-minute clinical quiz is reviewed by a US-licensed clinician. Treatment delivered to your door.
